Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 76
- Price
- $198.13
- Value
- $15,058
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•83 filings
BDX
BECTON DICKINSON & CO
Net sales of $1.3M over the last 3 months
3 sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$1,269,128
0 buyers · 3 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$2,785,303
5 distinct insiders
Highlighted alerts
6
22 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get BDX insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
BDX overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
100
Raw transactions
Everything returned by the filing
28
Voluntary view
P/S trades after deterministic checks
69
Administrative noise
Stored, never alerted
31
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- F
- Shares
- 190
- Price
- $0.00
- Footnotes
- 1
Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 76
- Price
- $183.70
- Value
- $13,961
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 165
- Price
- $188.49
- Value
- $31,101
Polen Thomas E Jr
Chairman, CEO and President
Sale 10b5-1
- Shares
- 4,152
- Price
- $185.00
- Value
- $768,120
Goette Roland
EVP and President, EMEA
SaleAlert
- Shares
- 2,438
- Price
- $180.84
- Value
- $440,888
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 75
- Price
- $157.13
- Value
- $11,785
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 75
- Price
- $152.80
- Value
- $11,460
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Sale 10b5-1
- Shares
- 1,100
- Price
- $145.66
- Value
- $160,226
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Sale 10b5-1
- Shares
- 1,100
- Price
- $151.48
- Value
- $166,628
Polen Thomas E Jr
Chairman, CEO and President
Sale 10b5-1
- Shares
- 2,764
- Price
- $146.35
- Value
- $404,511
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 75
- Price
- $147.35
- Value
- $11,051
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 74
- Price
- $151.94
- Value
- $11,244
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 75
- Price
- $156.83
- Value
- $11,762
Feld Michael
EVP, Chief Revenue Officer
Sale 10b5-1
- Shares
- 75
- Price
- $181.84
- Value
- $13,638
SCOTT BERTRAM L
Director
SaleAlert
- Shares
- 953
- Price
- $182.61
- Value
- $174,027
Feld Michael
EVP, CRO & Pres. Life Sciences
Sale 10b5-1
- Shares
- 75
- Price
- $202.73
- Value
- $15,205
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Sale 10b5-1
- Shares
- 1,010
- Price
- $206.54
- Value
- $208,605
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Sale 10b5-1
- Shares
- 600
- Price
- $209.00
- Value
- $125,400
Feld Michael
EVP, CRO & Pres. Life Sciences
Sale 10b5-1
- Shares
- 74
- Price
- $196.08
- Value
- $14,510
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm
Sale 10b5-1
- Shares
- 629
- Price
- $196.03
- Value
- $123,303
Feld Michael
EVP, CRO & Pres. Life Sciences
Sale 10b5-1
- Shares
- 75
- Price
- $193.36
- Value
- $14,502
SCOTT BERTRAM L
Director
SaleAlert
- Shares
- 217
- Price
- $176.58
- Value
- $38,318
Feld Michael
EVP & President, Life Sciences
Sale 10b5-1
- Shares
- 57
- Price
- $186.01
- Value
- $10,603
Feld Michael
EVP & President, Life Sciences
Sale 10b5-1
- Shares
- 58
- Price
- $181.03
- Value
- $10,500
Fraser Claire
Director
SaleAlert
- Shares
- 917
- Price
- $187.50
- Value
- $171,938
Feld Michael
EVP & President, Life Sciences
Sale 10b5-1
- Shares
- 57
- Price
- $197.99
- Value
- $11,285
HAYES GREGORY
Director
PurchaseAlert
- Shares
- 5,250
- Price
- $191.57
- Value
- $1,005,743
Fraser Claire
Director
SaleAlert
- Shares
- 863
- Price
- $192.30
- Value
- $165,955
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 76 | $198.13 | $15,058 | |
| Sep 28, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 76 | $183.70 | $13,961 | |
| Aug 26, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 165 | $188.49 | $31,101 | |
| Aug 13, 2026 | Polen Thomas E Jr Chairman, CEO and President | Sale | 4,152 | $185.00 | $768,120 | |
| Aug 11, 2026 | Goette Roland EVP and President, EMEA | Sale | 2,438 | $180.84 | $440,888 | |
| Jul 27, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 75 | $157.13 | $11,785 | |
| Jun 26, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 75 | $152.80 | $11,460 | |
| Jun 24, 2026 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $145.66 | $160,226 | |
| Jun 10, 2026 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $151.48 | $166,628 | |
| Jun 01, 2026 | Polen Thomas E Jr Chairman, CEO and President | Sale | 2,764 | $146.35 | $404,511 | |
| May 26, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 75 | $147.35 | $11,051 | |
| Apr 27, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 74 | $151.94 | $11,244 | |
| Mar 26, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 75 | $156.83 | $11,762 | |
| Feb 26, 2026 | Feld Michael EVP, Chief Revenue Officer | Sale | 75 | $181.84 | $13,638 | |
| Feb 18, 2026 | SCOTT BERTRAM L Director | Sale | 953 | $182.61 | $174,027 | |
| Jan 26, 2026 | Feld Michael EVP, CRO & Pres. Life Sciences | Sale | 75 | $202.73 | $15,205 | |
| Jan 15, 2026 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | 1,010 | $206.54 | $208,605 | |
| Jan 15, 2026 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | 600 | $209.00 | $125,400 | |
| Dec 26, 2025 | Feld Michael EVP, CRO & Pres. Life Sciences | Sale | 74 | $196.08 | $14,510 | |
| Dec 17, 2025 | Garrison Michael David EVP & Pres Med.Essntl&BioPharm | Sale | 629 | $196.03 | $123,303 | |
| Dec 01, 2025 | Feld Michael EVP, CRO & Pres. Life Sciences | Sale | 75 | $193.36 | $14,502 | |
| Nov 07, 2025 | SCOTT BERTRAM L Director | Sale | 217 | $176.58 | $38,318 | |
| Oct 27, 2025 | Feld Michael EVP & President, Life Sciences | Sale | 57 | $186.01 | $10,603 | |
| Sep 26, 2025 | Feld Michael EVP & President, Life Sciences | Sale | 58 | $181.03 | $10,500 | |
| Sep 10, 2025 | Fraser Claire Director | Sale | 917 | $187.50 | $171,938 | |
| Aug 22, 2025 | Feld Michael EVP & President, Life Sciences | Sale | 57 | $197.99 | $11,285 | |
| Aug 11, 2025 | HAYES GREGORY Director | Purchase | 5,250 | $191.57 | $1,005,743 | |
| Aug 08, 2025 | Fraser Claire Director | Sale | 863 | $192.30 | $165,955 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.